Zobrazeno 1 - 10
of 174
pro vyhledávání: '"I. V. Zhirov"'
Autor:
A. A. Syrkhaeva, M. A. Shariya, S. N. Nasonova, I. V. Zhirov, A. V. Shirkin, S. N. Tereshchenko, S. K. Ternovoy
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 96-100 (2024)
Aim. To evaluate and compare the accuracy of determining volemic status by remote dielectric sensing (ReDS) with computed tomography (CT) in patients with acute decompensated heart failure (ADHF).Materials and methods. In 33 patients with chronic hea
Externí odkaz:
https://doaj.org/article/090458d34d834ef8b591f35970ade841
Autor:
S. N. Tereshchenko, I. V. Zhirov, T. M. Uskach, M. A. Saidova, S. P. Golicyn, E. M. Rimskaya, S. N. Nasonova, O. Yu. Narusov, A. A. Safiullina, A. S. Tereshchenko, O. V. Stukalova
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 6-76 (2024)
The purpose of this guide is to assist cardiologists in the management of patients with chronic heart failure (CHF) in accordance with the available modern evidence base. This manual contains data on the diagnosis, treatment, and rehabilitation of pa
Externí odkaz:
https://doaj.org/article/8df12cf9f1184c3d9db14d4c09d356ad
Autor:
Y. O. Aksenova, Y. F. Osmolovskaya, A. A. Petrukhina, I. V. Zhirov, A. G. Beniashvili, S. N. Tereshchenko, M. A. Morozova
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 100-106 (2024)
Heart failure is a serious chronic illness and a global healthcare problem. Patients with heart failure have increased hospital readmission rates and mortality around the world. Heart failure often coexists with comorbidities of which cognitive impai
Externí odkaz:
https://doaj.org/article/eac23a55f571464eac6b4c7a60d8493a
Autor:
Yu. F. Osmolovskaya, A. A. Petrukhina, Yu. O. Aksenova, I. V. Zhirov, A. G. Beniashvili, M. A. Morozova, S. N. Tereshchenko
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 7 (2024)
Aim. To study the effectiveness of virtual reality (VR) relaxation to correct symptoms of depression, anxiety, emotional and cognitive disorders in patients with heart failure (HF).Material and methods. The study included 100 patients with HF aged 21
Externí odkaz:
https://doaj.org/article/04506175e8c948a7931eda030688354d
Autor:
E. V. Shlyakhto, Yu. N. Belenkov, S. A. Boytsov, S. V. Villevalde, A. S. Galyavich, N. G. Glezer, N. E. Zvartau, Zh. D. Kobalava, Yu. M. Lopatin, V. Yu. Mareev, S. N. Tereshchenko, I. V. Fomin, O. L. Barbarash, N. G. Vinogradova, D. V. Duplyakov, I. V. Zhirov, E. D. Kosmacheva, V. A. Nevzorova, O. M. Reitblat, A. E. Solovieva, E. A. Zorina
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 10 (2023)
Aim. To describe demographic and clinical laboratory characteristics, concomitant diseases and drug therapy of outpatients with heart failure (HF) in the Russian Federation.Material and methods. An interim analysis of a prospective observational mult
Externí odkaz:
https://doaj.org/article/8d00867d69f04d74aa884faff12c660c
Autor:
I. E. Chazova, Yu. V. Zhernakova, N. V. Blinova, T. N. Markova, N. V. Mazurina, I. V. Zhirov, T. M. Uskach, A. A. Safiullina, O. Iu. Mironova, E. M. Elfimova, A. Yu. Litvin, E. A. Zheleznova, Yu. A. Yuricheva, V. A. Azizov, E. A. Grigorenko, Z. Ya. Rahimov, S. D. Kasymova, I. I. Mustafaev, A. R. Narzullaeva, A. G. Polupanov, A. Sh. Sarybaev, N. Z. Srozhidinova
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 3, Pp 6-56 (2022)
Disclaimer. The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event
Externí odkaz:
https://doaj.org/article/b4400d16e0f04821a82c5e569b0dd6a8
Autor:
E. V. Shlyakhto, Yu. N. Belenkov, S. I. Boytsov, S. V. Villevalde, A. S. Galyavich, M. G. Glezer, N. E. Zvartau, Zh. Kobalava, Yu. M. Lopatin, Yu. V. Mareev, S. N. Tereshchenko, I. V. Fomin, O. L. Barbarash, N. G. Vinogradova, D. V. Duplyakov, I. V. Zhirov, E. D. Kosmacheva, V. A. Nevzorova, O. M. Reitblat, A. E. Soloveva, E. A. Zorina
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 6 (2023)
Heart failure (HF) is a global health problem. Despite advances in the development of effective treatments for patients with heart failure, morbidity and mortality from remain high, and the prognosis is poor. However, there is potential to improve ou
Externí odkaz:
https://doaj.org/article/81e00cc515b145e79cd24023bb440836
Autor:
S. A. Boytsov, N. V. Pogosova, A. A. Ansheles, V. A. Badtieva, T. V. Balakhonova, O. L. Barbarash, Yu. A. Vasyuk, N. G. Gambaryan, G. E. Gendlin, S. P. Golitsyn, O. M. Drapkina, L. Yu. Drozdova, M. V. Yezhov, A. I. Ershova, I. V. Zhirov, Yu. A. Karpov, Zh. D. Kobalava, A. V. Kontsevaya, A. Yu. Litvin, M. M. Lukyanov, S. Yu. Martsevich, S. T. Matskeplishvili, V. A. Metelskaya, A. N. Meshkov, I. E. Mishina, E. P. Panchenko, A. B. Popova, I. V. Sergienko, M. D. Smirnova, M. I. Smirnova, O. Yu. Sokolova, A. V. Starodubova, O. Yu. Sukhareva, S. K. Ternovoy, O. N. Tkacheva, S. A. Shalnova, M. V. Shestakova
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 5 (2023)
Russian Society of Cardiology, National Society of Preventive Cardiology
Externí odkaz:
https://doaj.org/article/6af42f5729d84c1784d8c6fd021217b0
Autor:
S. A. Boytsov, S. N. Tereshchenko, S. V. Villevalde, A. S. Galyavich, A. A. Garganeeva, M. G. Glezer, D. V. Duplyakov, I. V. Zhirov, Zh. D. Kobalava, Yu. M. Lopatin, S. V. Nedogoda, E. I. Tarlovskaya
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 4 (2023)
The objective of this advisory board meeting was to discuss the place of vericiguat in the treatment algorithm for heart failure with reduced ejection fraction and the necessary requirements for its successful application in clinical practice.
Externí odkaz:
https://doaj.org/article/44182106205149daae9ba73ec79ad3b4
Autor:
M. V. Zhuravleva, S. N. Tereshchenko, I. V. Zhirov, S. V. Nedogoda, Yu. V. Gagarina, E. A. Shabalina
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 3 (2023)
Aim. To evaluate the cost-effectiveness of achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health Development" when using drugs valsartan+sacubitril, dapagliflozin and empagliflozin i
Externí odkaz:
https://doaj.org/article/f476d2a5aaba400aad79ebda1c3767bc